Gabriella Baio

Gabriella Baio

Auto-generated profile, based on publicly available information

Gabriella Baio

Department of Diagnostic Imaging, IRCCS Azienda Ospedaliera Universitaria San Martino — IST – National Cancer Institute, Largo Rosanna Benzi, 10, 16100, Genoa, Italy

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2008 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
Fabio PastorinoFabio Pastorino
Fabio Pastorino
DPDaniela Di Paolo
Daniela Di Paolo
FPFederica Piccardi
Federica Piccardi
BNBeatrice Nico
Beatrice Nico
DRDomenico Ribatti
Domenico Ribatti
MPMirco Ponzoni
Mirco Ponzoni
Purpose:In vivo evaluation of good manufacturing practice-grade targeted liposomal doxorubicin (TVT-DOX), bound to a CD13 isoform expressed on the vasculature of solid tumors, in human tumor xenografts of neuroblastoma, ovarian cancer, and lung cancer. Experimental Design: Mice were implanted with lung, ovarian, or neuroblastoma tumor cells via the pulmonary, peritoneal, or orthotopic (adrenal gland) routes, respectively, and treated, at different days post inoculation, with multiple doses of doxorubicin, administered either free or encapsulated in untargeted liposomes (Caelyx) or in TVT-DOX. The effect of TVT-DOX treatment on tumor cell proliferation, viability, apoptosis, and angiogenesis was studied by immunohistochemical analyses of neoplastic tissues and using the chick embryo chorioallantoic membrane assay. Results: Compared with the three control groups (no doxorubicin, free doxorubicin, or Caelyx), statistically significant improvements in survival was seen in all three animal models following treatment with 5 mg/kg (maximum tolerated dose) of TVT-DOX, with long-term survivors occurring in the neuroblastoma group; increased survival was also seen at a dose of 1.7 mg/kg in mice bearing neuroblastoma or ovarian cancer. Minimal residual disease after surgical removal of neuroblastoma primary mass, and the enhanced response to TVT-DOX, was visualized and quantified by bioluminescence imaging and with magnetic resonance imaging. When treated with TVT-DOX, compared with Caelyx, all three tumor models, as assayed by immunohistochemistry and chorioallantoic membrane, showed statistically significant reductions in cell proliferation, blood vessel density, and microvessel area, showing increased cell apoptosis. Conclusion: TVT-DOX should be evaluated as a novel angiostatic strategy for adjuvant therapy of solid tumors.

22 March 2011 in European Radiology
Verified
Journal Article
Closed access
PDF file
Alberto Stefano TagliaficoAlberto Stefano Tagliafico
Alberto Stefano Tagliafico
MCMassimo Calabrese
Massimo Calabrese
MPMatteo Puntoni
Matteo Puntoni
DPDaniele Pace
Daniele Pace
GBGabriella Baio
Gabriella Baio
CMCarlo Martinoli
Carlo Martinoli

19 December 2013 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
DVDonatella Vecchio
Donatella Vecchio
ADAntonio Daga
Antonio Daga
ECElisa Carra
Elisa Carra
DMDaniela Marubbi
Daniela Marubbi
GBGabriella Baio
Gabriella Baio
GFGuido Frosina
Guido Frosina
We have previously shown that pharmacological inhibition of ataxia telangiectasia mutated (ATM) protein sensitizes glioblastoma-initiating cells (GICs) to ionizing radiation (IR). Herein, we report the experimental conditions to overcome GIC radioresistance in vitro using the specific ATM inhibitor KU-60019, two major determinants of the tumor response to this drug and the absence of toxicity of this treatment in vitro and in vivo. Repeated treatments with KU-60019 followed by IR substantially delayed GIC proliferation in vitro and even eradicated radioresistant cells, whereas GIC treated with vehicle plus radiation recovered early and expanded. The tumor response to the drug occurred under a cutoff level of expression of TP53 and over a cutoff level of expression of phosphatidylinositol 3-kinase (PI3K). No increased clastogenicity or point mutagenicity was induced by KU-60019 plus radiation when compared to vehicle plus radiation. No significant histological changes to the brain or other organs were observed after prolonged infusion into the brain of KU-60019 at millimolar concentrations. Taken together, these findings suggest that GIC-driven tumors with low expression of TP53 and high expression of PI3K might be effectively and safely radiosensitized by KU-60019.

4 August 2014 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
DVDonatella Vecchio
Donatella Vecchio
ADAntonio Daga
Antonio Daga
ECElisa Carra
Elisa Carra
DMDaniela Marubbi
Daniela Marubbi
ARAlessandro Raso
Alessandro Raso
GFGuido Frosina
Guido Frosina
We have recently reported that glioblastoma (GB)‐initiating cells (GIC) with low expression and/or mutation of TP53 and high expression of PI3K (“responder” genetic profile) can be effectively and safely radiosensitized by the ATM inhibitor KU60019. We report here on drug's diffusion and elimination from the animal body and brain, its effects on orthotopic GB and efficacy toward pediatric GIC. Healthy mice were infused by convection enhanced delivery (CED) with KU60019 and the drug kinetics followed by high performance liquid chromatography–mass spectrometry. Already at the end of CED, KU60019 had diffused from the injection site to the ipsilateral and, to a lower extent, controlateral hemisphere. After 24 hr, no drug could be detected all over the brain or in other organs, indicating rapid draining and excretion. After intraperitoneal injection, traces only of KU60019 could be detected in the brain, indicating inability to cross the brain–blood barrier. Consistent with the induction of cell cycle progression previously observed in vitro , KU60019 stimulated proliferation of orthotopic GB cells with the highest effect observed 96 hr after drug delivery. Adult GIC with high expression of TP53 and low expression of PI3K could be radiosensitized by KU60019, although less promptly than GIC bearing the “responder” profile. Consistent with the kinetics of proliferation induction, the highest radiosensitizing effect was observed 96 hr after delivery of KU60019 to GIC. Pediatric GIC could be similarly radiosensitized after exposure to KU60019. The results indicate that ATM inhibition may allow to radiosensitize a wide range of adult and pediatric high‐grade gliomas.

5 January 2017 in Leukemia
Verified
Journal Article
Closed access
Giovanna CutronaGiovanna Cutrona
Giovanna Cutrona
SMS Matis
S Matis
MCM Colombo
M Colombo
CMC Massucco
C Massucco
GBG Baio
G Baio
MFM Ferrarini
M Ferrarini

1 June 2012 in British Journal of Radiology
Verified
Journal Article
Closed access
Alberto Stefano TagliaficoAlberto Stefano Tagliafico
Alberto Stefano Tagliafico
GSG Succio
G Succio
CNC E Neumaier
C E Neumaier
GBG Baio
G Baio
GSG Serafini
G Serafini
CMC Martinoli
C Martinoli
The purpose of our study was to determine whether a three-dimensional (3D) isotropic resolution fast spin echo sequence (FSE-cube) has similar image quality and diagnostic performance to a routine MRI protocol for brachial plexus evaluation in volunteers and symptomatic patients at 3.0 T. Institutional review board approval and written informed consent were guaranteed. In this prospective study FSE-cube was added to the standard brachial plexus examination protocol in eight patients (mean age, 50.2 years) with brachial plexus pathologies and in six volunteers (mean age, 54 years). Nerve visibility, tissue contrast, edge sharpness, image blurring, motion artefact and acquisition time were calculated for FSE-cube sequences and for the standard protocol on a standardised five-point scale. The visibility of brachial plexus nerve and surrounding tissues at four levels (roots, interscalene area, costoclavicular space and axillary level) was assessed. Image quality and nerve visibility did not significantly differ between FSE-cube and the standard protocol (p>0.05). Acquisition time was statistically and clinically significantly shorter with FSE-cube (p<0.05). Pathological findings were seen equally well with FSE-cube and the standard protocol. 3D FSE-cube provided similar image quality in a shorter acquisition time and enabled excellent visualisation of brachial plexus anatomy and pathology in any orientation, regardless of the original scanning plane.